Insilico Medicine announces oral presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in mesothelioma and advanced solid tumors - EurekAlert!
Stanford performs first PITAC procedure for mesothelioma in North America - EurekAlert!
Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options - EurekAlert!
FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
Targeting factors for chemoprevention and cancer interception to tackle mesothelioma - EurekAlert
